Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission-Reference-Cited by-同舟云学术

Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission

Published:2020-05-10 Issue:12 Volume:55 Page:2244-2253
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Shouval Roni,Labopin Myriam,Bomze David,Baerlocher Gabriela M.,Capria Saveria,Blaise Didier^ORCID,Hänel Mathias,Forcade Edouard,Huynh Anne,Saccardi Riccardo,Milone Giuseppe^ORCID,Zuckerman Tsila^ORCID,Reményi Péter,Versluis Jurjen,Esteve Jordi,Gorin Norbert Claude,Mohty Mohamad,Nagler Arnon

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0936-z.pdf

Reference55 articles.

1. Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–47. https://doi.org/10.1182/blood-2016-08-733196

2. Marcucci G, Haferlach T, Dohner H. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J Clin Oncol. 2011;29:475–86. https://doi.org/10.1200/JCO.2010.30.2554

3. Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood. 2002;99:4326–35.

4. Gale RE, Green C, Allen C, Mead AJ, Burnett AK, Hills RK, et al. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood. 2008;111:2776–84. https://doi.org/10.1182/blood-2007-08-109090

5. Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N. Engl J Med. 2008;358:1909–18. https://doi.org/10.1056/NEJMoa074306

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Childhood Acute Myeloid Leukemia: Diagnosis and Novel Treatment;Pharmaceuticals;2023-11-15

2. Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT;Bone Marrow Transplantation;2023-08-08

3. Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE);Bone Marrow Transplantation;2023-03-09

4. Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy;Transplantation and Cellular Therapy;2022-09

5. Autologous stem cell transplantation ( ASCT ) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT;Cancer Medicine;2022-07-26